Mebeverine hydrochloride
CAS No. 2753-45-9
Mebeverine hydrochloride ( —— )
Catalog No. M13843 CAS No. 2753-45-9
Mebeverine is a drug whose major therapeutic role is in the treatment of irritable bowel syndrome (IBS) and the associated abdominal cramping.
Purity : >98%(HPLC)
Size | Price / USD | Stock | Quantity |
5MG | 37 | In Stock |
|
10MG | 45 | In Stock |
|
25MG | 63 | In Stock |
|
50MG | 101 | In Stock |
|
100MG | 131 | In Stock |
|
200MG | 185 | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMebeverine hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionMebeverine is a drug whose major therapeutic role is in the treatment of irritable bowel syndrome (IBS) and the associated abdominal cramping.
-
DescriptionMebeverine is a drug whose major therapeutic role is in the treatment of irritable bowel syndrome (IBS) and the associated abdominal cramping. It works by relaxing the muscles in and around the gut. It is a musculotropic antispasmodic drug without anticholinergic side-effects. The drug is also indicated for treatment of gastrointestinal spasm secondary to organic disorder.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2753-45-9
-
Formula Weight466.01
-
Molecular FormulaC25H36ClNO5
-
Purity>98%(HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESCl.CCN(CCCCOC(=O)C1=CC(OC)=C(OC)C=C1)C(C)CC1=CC=C(OC)C=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Crenulatin
Crenulatin has dual- direction effects on apoptosis of cerebral microvascular endothelial cells, inhibitive effect in 25 mg/L and stimulative effect in 100 mg/L group, respectively; the mechanism is related to the alterations of Fas/Bcl-2 expression and caspase-3 activity.
-
Alopecurone A
Alopecurone A exhibits potent inhibitory activity on MRP1.
-
Moth Cytochrome C (M...
Moth Cytochrome C (MCC) (88-103), derived from the carboxyl terminus of moth cytochrome c, induces positive selection of TCR transgenic thymocytes.This peptide is derived from the carboxyl terminus of moth cytochrome c. Thymic positive and negative selections govern the development of a self-MHC-reactive, yet self-tolerant, T cell repertoire.